(Q35692851)

9 August 2017

1 reference

title

Behavioral and psychologic symptoms of dementia (English)

1 reference

9 August 2017

0 references

Sanford I Finkel

1

1 reference

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Clinics in geriatric medicine

9 August 2017

published in

1 reference

9 August 2017

volume

19

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

799-824

1 reference

A metaanalysis of controlled trials of neuroleptic treatment in dementia

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Agitated behaviors in the elderly. I. A conceptual review

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Resident behavior and staff distress in the nursing home.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Physical restraints and agitation in nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Efficacy of antipsychotic medications in behaviorally disturbed dementia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A regulatory perspective on psychiatric syndromes in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Characteristics of sleep disturbance in community-dwelling Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Overview of depression and psychosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A Study of Visual Hallucinations in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Occipital atrophy is associated with visual hallucinations in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Evidence of a Monoaminergic-Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Operational criteria for senile dementia of Lewy body type (SDLT)

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Prevalence and correlates of anxiety in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Apathy: a neuropsychiatric syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

The prevalence and clinical correlates of apathy and irritability in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A one-year follow-up study of depression in dementia sufferers.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Types of multi-infarct dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Impact of cognitive impairment on wandering behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

The Algase Wandering Scale: initial psychometrics of a new caregiver reporting tool.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Effects of individualized versus classical "relaxation" music on the frequency of agitation in elderly persons with Alzheimer's disease and related disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A randomized trial of dementia care in nursing homes.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Pharmacological approaches in the treatment of senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Cerebrospinal fluid acetylcholine and choline in vascular dementia of Binswanger and multiple small infarct types as compared with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Major depression in primary dementia. Clinical and neuropathologic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

The neuropathology of aminergic nuclei in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Clinical and neuropathological correlates of depression in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A study of premorbid personality and behavioural and psychological symptoms of dementia in nursing home residents

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Age, personality, and the spontaneous self-concept

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Life-span perspective of personality in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Personality changes in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Adjustment to residential placement in Alzheimer disease patients: does premorbid personality matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Effects of environmental stimulation on biochemical and psychological variables in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Neuroimaging and the origin of psychiatric symptoms in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

SPECT findings on psychosis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A SPECT study of delusions in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Abnormal brain glucose metabolism in the delusional misidentification syndromes: a positron emission tomography study in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Physician management of the demented patient

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Sundown syndrome in institutionalized elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Alteration of regional cerebral glucose utilization with delusions in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A randomized, placebo-controlled trial of thiothixene in agitated, demented nursing home patients'

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Comparison of Thioridazine and Diazepam in the Control of Nonpsychotic Symptoms Associated with Senility: Double-Blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Valproate in the treatment of behavioral agitation in elderly patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Sodium valproate in the treatment of behavioral disturbance in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Placebo-controlled study of divalproex sodium for agitation in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Conventional vs. newer antipsychotics in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

1 reference

7 January 2021

Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Long-Term use of quetiapine in elderly patients with psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

ECT: an effective treatment in the screaming demented patient

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Efficacy of interventions with caregivers: a reanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Caregiver well-being: a multidimensional examination of family caregivers of demented adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Psychiatric and physical morbidity effects of caregiving

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Symptoms of mental impairment among elderly adults and their effects on family caregivers.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Emotional distress amongst the supporters of the elderly mentally infirm.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

Predictors of institutionalization among caregivers of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0690%2803%2900046-6

7 January 2021

10.1016/S0749-0690(03)00046-6

Identifiers

DOI

1 reference

9 August 2017

1 reference